Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Handcrafted in Texas Vegan Pharmaceutical-Grade Peptides
"Better" depends on individual response, tolerance, medical history, and specific metabolic goals
The albumin-binding domain as a scaffold for protein engineering
Cell 37 MuhlenhoffU.MolikS.GodoyJ
You are on other medications, supplements or following other complementary or integrative health approaches
NIH has released four new SBIR/STTR solicitations (first deadline for all solicitations is September 8, 2026): Parent SBIR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track SBIR awards Parent STTR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track STTR awards SBIR Phase IIB Strategic Breakthrough Award (Clinical Trial Optional) accepts Phase IIB Strategic Breakthrough SBIR awards (for Phase II awardees) SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Clinical Trial Optional) accepts CRP awards (for Phase II awardees) Updated summaries of the research interests, budget waiver topics, and award mechanisms supported by individual Institutes and Centers (ICs) are now housed on the Small Business Funding Considerations and Contacts webpage
US$ 28.10
US$ 21.62
US$ 28.49
